A legal obligation where the process is everything.
Collection, management and reporting of reports, with procedures that leave no room for improvisation.
Pharmacovigilance allows no approximation.
Drug safety after market authorization is a stringent regulatory obligation: every adverse reaction report must be collected, assessed, documented and reported within the required timeframes and manner. A delay or a process error is not an inefficiency: it is a non-conformity with regulatory consequences.
Outsourcing pharmacovigilance — in whole or in part — requires a partner with consolidated procedures, defined responsibilities and guaranteed operational continuity.
Merqurio supports pharmacovigilance activities with structured and traceable processes.
Interception of adverse reaction reports from all channels, including those of medical information and scientific information.
Processing of reports according to procedure, with documentation and reporting within the required timeframes.
Pharmacovigilance is linked to medical information and to the scientific information network, which intercept reports in the field.
Procedures, clear responsibilities and operational continuity to ensure conformity over time.
A partner with consolidated procedures and guaranteed continuity.
A link with medical information and the information network.
Absorb growing volumes while maintaining rigor.
Documented traceability and reporting.
Pharmacovigilance has always been part of the Merqurio structure: the reps are integrated into the pharmacovigilance process, and the medical direction oversees the process.
The quality management and IT security systems are ISO 9001 and ISO 27001 certified. Pharmacovigilance is not an isolated service: it is integrated with medical information and with the scientific information network that intercepts reports in the field.
